| Kelly Ann Schmalstich, ACNP-AG | |
|
6767 29th St Fl 2, Greeley, CO 80634-5474 | |
| (970) 224-9102 | |
| (970) 224-9112 |
| Full Name | Kelly Ann Schmalstich |
|---|---|
| Gender | Female |
| Speciality | Nurse Practitioner |
| Experience | 4 Years |
| Location | 6767 29th St Fl 2, Greeley, Colorado |
| Accepts Medicare Assignments | Yes. She accepts the Medicare-approved amount; you will not be billed for any more than the Medicare deductible and coinsurance. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1356950299 | NPI | - | NPPES |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 364SA2100X | Clinical Nurse Specialist - Acute Care | APN.0995629-NP (Colorado) | Primary |
| Facility Name | Location | Facility Type |
|---|---|---|
| Uchealth Greeley Hospital | Greeley, CO | Hospital |
| Medical Center Of The Rockies | Loveland, CO | Hospital |
| Poudre Valley Hospital | Fort collins, CO | Hospital |
| Group Practice Name | Group PECOS PAC ID | No. of Members |
|---|---|---|
| Poudre Valley Medical Group Llc | 9638208549 | 1605 |
News Archive
Adocia, a biotechnology company specializing in the development of ‘best-in-class' medicines from already approved therapeutic proteins, announced today that it had agreed with Eli Lilly and Company not to continue further joint research under the licensing agreement signed in December 2011 relating to use of Adocia's BioChaperone(R) technology for the formulation of fast acting insulin analog formulated with the BioChaperone(R) technology. Consequently, the two companies have terminated the collaboration.
The Research Foundation of SUNY, which supports the advancement of education, research and discovery at the State University of New York, today announced it signed a licensing agreement with Biosense Webster Inc. for the rights to an Upstate Medical University innovation that helps locate and treat life-threatening heart arrhythmias.
The body's immune system is an excellent weapon against many diseases. For more than 100 years, immunology and immunotherapy have played an ever-increasing role in the understanding and treatment of cancer.
A recent study by researchers from Sweden and the United Kingdom shows that CRISPR/Cas9-based genomic engineering can prompt unwanted on-target effects, and highlights the complexity of human DNA repair mechanisms in the presence of the powerful prokaryotic Cas9 nuclease. The paper is currently available on the bioRxiv* preprint server.
The age of the installed base of medical imaging equipment is continuing to decline dramatically, placing patients at avoidable risk. To draw attention to this deterioration in equipment and the potentially serious consequences, COCIR is launching a new infographic at the 3rd edition of the EuroSafe Imaging presence at the European Congress of Radiology.
› Verified 1 days ago
| Entity Name | Poudre Valley Medical Group Llc |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1366763260 PECOS PAC ID: 9638208549 Enrollment ID: O20100602000122 |
News Archive
Adocia, a biotechnology company specializing in the development of ‘best-in-class' medicines from already approved therapeutic proteins, announced today that it had agreed with Eli Lilly and Company not to continue further joint research under the licensing agreement signed in December 2011 relating to use of Adocia's BioChaperone(R) technology for the formulation of fast acting insulin analog formulated with the BioChaperone(R) technology. Consequently, the two companies have terminated the collaboration.
The Research Foundation of SUNY, which supports the advancement of education, research and discovery at the State University of New York, today announced it signed a licensing agreement with Biosense Webster Inc. for the rights to an Upstate Medical University innovation that helps locate and treat life-threatening heart arrhythmias.
The body's immune system is an excellent weapon against many diseases. For more than 100 years, immunology and immunotherapy have played an ever-increasing role in the understanding and treatment of cancer.
A recent study by researchers from Sweden and the United Kingdom shows that CRISPR/Cas9-based genomic engineering can prompt unwanted on-target effects, and highlights the complexity of human DNA repair mechanisms in the presence of the powerful prokaryotic Cas9 nuclease. The paper is currently available on the bioRxiv* preprint server.
The age of the installed base of medical imaging equipment is continuing to decline dramatically, placing patients at avoidable risk. To draw attention to this deterioration in equipment and the potentially serious consequences, COCIR is launching a new infographic at the 3rd edition of the EuroSafe Imaging presence at the European Congress of Radiology.
› Verified 1 days ago
| Mailing Address | Practice Location Address |
|---|---|
| Kelly Ann Schmalstich, ACNP-AG 6767 29th St Fl 2, Greeley, CO 80634-5474 Ph: (970) 224-9102 | Kelly Ann Schmalstich, ACNP-AG 6767 29th St Fl 2, Greeley, CO 80634-5474 Ph: (970) 224-9102 |
News Archive
Adocia, a biotechnology company specializing in the development of ‘best-in-class' medicines from already approved therapeutic proteins, announced today that it had agreed with Eli Lilly and Company not to continue further joint research under the licensing agreement signed in December 2011 relating to use of Adocia's BioChaperone(R) technology for the formulation of fast acting insulin analog formulated with the BioChaperone(R) technology. Consequently, the two companies have terminated the collaboration.
The Research Foundation of SUNY, which supports the advancement of education, research and discovery at the State University of New York, today announced it signed a licensing agreement with Biosense Webster Inc. for the rights to an Upstate Medical University innovation that helps locate and treat life-threatening heart arrhythmias.
The body's immune system is an excellent weapon against many diseases. For more than 100 years, immunology and immunotherapy have played an ever-increasing role in the understanding and treatment of cancer.
A recent study by researchers from Sweden and the United Kingdom shows that CRISPR/Cas9-based genomic engineering can prompt unwanted on-target effects, and highlights the complexity of human DNA repair mechanisms in the presence of the powerful prokaryotic Cas9 nuclease. The paper is currently available on the bioRxiv* preprint server.
The age of the installed base of medical imaging equipment is continuing to decline dramatically, placing patients at avoidable risk. To draw attention to this deterioration in equipment and the potentially serious consequences, COCIR is launching a new infographic at the 3rd edition of the EuroSafe Imaging presence at the European Congress of Radiology.
› Verified 1 days ago
Mr. Daniel A. Frantz, PMHCNS-BC Clinical Nurse Specialist Medicare: Accepting Medicare Assignments Practice Location: 1300 N 17th Ave, Greeley, CO 80631 Phone: 970-347-2120 Fax: 970-346-9800 | |
Mary Catherine Frantz, RN,MS,CS,CACIII Clinical Nurse Specialist Medicare: Not Enrolled in Medicare Practice Location: 3211 W 20th St Ste D, Greeley, CO 80634 Phone: 970-353-2000 Fax: 970-356-4827 | |
Karen Jean Thurman, PMH,CNS/NP Clinical Nurse Specialist Medicare: Not Enrolled in Medicare Practice Location: 1300 N 17th Ave, Greeley, CO 80631 Phone: 970-347-2120 Fax: 970-346-9800 | |
Mrs. Susan Jo Ponder, RN, CNS/RXN Clinical Nurse Specialist Medicare: Medicare Enrolled Practice Location: 1919 65th Ave Ste 3, Greeley, CO 80634 Phone: 970-590-1138 Fax: 970-356-7437 | |
Jeanette Luella Fraser, APRN Clinical Nurse Specialist Medicare: Not Enrolled in Medicare Practice Location: 24489 County Road 54, Greeley, CO 80631 Phone: 970-689-9925 |